Geng L

No ORCID on file · 11 papers in corpus · active 1994-2026

Study types

  • other 2
  • article 1

Condition tags

  • endometriosis 3
  • infertility 2
other 2026
Journal of molecular medicine (Berlin, Germany) ·doi:10.1007/s00109-026-02655-z

This study evaluates the synergistic therapeutic effect of metformin (MET) combined with medroxyprogesterone acetate (MPA) on endometriosis (EM) and investigates the involvement of the steroid receptor coactivator-1 (SRC-1) and mitogen-indu…

2025
Archives of gynecology and obstetrics ·doi:10.1007/s00404-024-07850-2

PurposeFor unexpected low-prognosis patients (Group 1 and Group 2) defined by POSEIDON criteria, how to maximize the live birth rate while controlling the multiple birth rate by tailoring the embryo transfer number and quality?MethodsThis w…

2025
Scientific reports ·doi:10.1038/s41598-025-27002-z

Inflammatory bowel disease (IBD) is a systemic condition with multifactorial origins. Mitochondria and ferroptosis have been implicated in the disease, but their potential interaction in IBD remains unclear. Therefore, investigating the rel…

2025
Health policy and planning ·doi:10.1093/heapol/czaf045

Infertility, a widely prevalent condition globally, incurs high economic burdens. Assisted reproductive technologies (ARTs) are effective treatments, but public health financing in low- and middle-income countries (LMICs) rarely covers ART …

2024
Journal of ovarian research ·doi:10.1186/s13048-024-01443-y

BackgroundThe 2016 Patient-Oriented Strategy Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria redefined the poor responders as low prognosis patients. The embryo transfer strategy for POSEIDON patients remained to be addressed.…

2022
BMJ open ·doi:10.1136/bmjopen-2022-067838

ObjectivesTo establish visualised prediction models of low fertilisation rate (LFR) and total fertilisation failure (TFF) for patients in conventional in vitro fertilisation (IVF) cycles.DesignA retrospective cohort study.SettingData from A…

2019
Medicine ·doi:10.1097/md.0000000000015512

At present, the precise role of human menopausal gonadotropin (HMG) and recombinant luteinizing hormone (rLH) supplementation at an early time of follicular phase on in vitro fertilization (IVF)/intra cytoplasmatic sperm injection (ICSI) ou…

2017
Medicine ·doi:10.1097/md.0000000000006124

BackgroundTo evaluate the efficacy and safety of 10 mg and 25 mg mifepristone per day compared with 3.75 mg enantone in treating uterine fibroids.MethodsThis is a Multicenter randomized controlled trial. A total of 501 subjects with symptom…

2015
PloS one ·doi:10.1371/journal.pone.0139146

This study investigated the risk factors and early predictors for heterotopic pregnancy (HP) after in vitro fertilization and embryo transfer (IVF-ET). From January 2008 to January 2013, 41 cases of HP and 72 cases of intrauterine twin preg…

other 2011
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-9-9

BACKGROUND: To evaluate basal testosterone (T) levels during follicular phase of the menstrual cycle as a predictor for ovarian response and in vitro fertilization (IVF) outcome. METHOD: We analyzed data retrospectively from hospital-based…

article 1994
Zhonghua fu chan ke za zhi

Sixty patients with endometriosis, stage I-IV, diagnosed by laparoscopy or laparotomy, were treated with 200 micrograms of domestic luteinizing hormone-releasing hormone analogue (LHRH-A) subcutaneously twice daily, starting from the early …